Ottawa, Ontario–(Newsfile Corp. – February 12, 2025) – More than half of Canadians lack a comprehensive retirement plan, and of those Canadians without a plan only 44% expect to retire comfortably. This puts many at risk of financial insecurity in retirement.
To help Canadians take control of their financial future, the Canadian Institute of Actuaries (CIA) has released a new statement, Helping Canadians Prepare for the Risks of Retirement, and an accompanying fact sheet, Planning for a Secure Retirement. These resources highlight the importance of early and proactive retirement planning while offering practical strategies to help Canadians achieve financial security in their retirement years.
“A secure retirement doesn’t happen by chance,” says CIA President Conrad Ferguson, FCIA. “Planning ahead and understanding the risks can make all the difference. These CIA resources provide clear, actionable guidance for financial professionals and individuals alike, empowering Canadians to navigate these challenges effectively.”
Key takeaways include:
The statement is designed to help financial professionals support their clients, while the fact sheet provides simple steps and key considerations which individuals should be aware of. Both resources are available in English and French on the CIA’s website.
Subscribe to the CIA’s mailing list for news and updates.
Media contact
Josée Gonthier
Manager, Language Services and Public Affairs
Canadian Institute of Actuaries
media@cia-ica.ca
613-236-8196 ext. 106
The Canadian Institute of Actuaries (CIA) is the qualifying and governing body of the actuarial profession in Canada. We develop and uphold rigorous standards, share our risk management expertise and advance actuarial science to improve lives in Canada and around the world. Our more than 6,000 members apply their knowledge of math, statistics, data analytics and business in providing services and advice of the highest quality to help Canadian people and organizations face the future with confidence.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240576
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…